metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty...
Journal Information
Vol. 27. Issue 3.
(May - June 2022)
Share
Share
Download PDF
More article options
Visits
1583
Vol. 27. Issue 3.
(May - June 2022)
Original article
Open Access
Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease
Visits
1583
Yongsang Seoc,1, Gi-Ho Sungd,e,1, Sangheun Leea,b,*, Ki Jun Hana,b
a Department of Internal Medicine, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon Metropolitan city, Republic of Korea
b Division of Hepatology, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon Metropolitan city, Republic of Korea
c Department of Emergency Medicine, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon Metropolitan city, Republic of Korea
d Translational Research Division, Biomedical Institute of Mycological Resource, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Republic of Korea
e Department of Microbiology, College of Medicine, Catholic Kwandong University, Gangneung-si, Gangwon-do, Republic of Korea
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (2)
Table 1. Clinical characteristics in the study population in Set 1.
Table 2. Associations between sleep duration and quality and the risk of fatty liver in clinically relevant subgroups.
Show moreShow less
Abstract
Introduction and objectives

Recently, interest in the relationship between weekend catch-up sleep (WCUS) and chronic diseases is increasing. We aimed to study the correlation between sleep duration and non-alcoholic fatty liver disease (NAFLD), an emerging metabolic disease.

Materials and methods

Data on sleep duration from the Korea National Health and Nutrition Examination Survey was recorded. The subjects were divided into three groups according to the duration of WCUS: Group 1, those who slept for less than 7 hours in a week; Group 2, those who slept for less than 7 hours on weekdays but more than 7 hours on weekends (those with WCUS pattern); and Group 3, those who slept for more than 7 hours in a week. Multivariate logistic regression analysis was used to analyze the correlation between sleep duration and NAFLD.

Results

A mean sleep time of 7 hours or more showed a significant negative relationship with NAFLD (odds ratio [OR]: 0.84, 95% confidence interval [CI]: 0.79–0.89 in all; OR 0.91, 95%CI 0.84–0.99 in males; OR 0.86, 95%CI 0.79–0.94 in females). Groups 2 and 3 showed significant negative relationships with NAFLD when Group 1 was used as a reference (Group 2; OR: 0.80, 95%CI: 0.70–0.92, Group 3; OR: 0.73, 95%CI: 0.66–0.82). WCUS showed similar correlations with NAFLD, regardless of sex.

Conclusions

WCUS and sleep duration are significantly associated with NAFLD. A prospective cohort study is needed to prove the causal effects.

Keywords:
Nonalcoholic fatty liver disease
Metabolic disorders
Sleep habits
Sleep duration
Weekend catch-up sleep
Abbreviation:
NAFLD
WCUS
KNHANES
AST
ALT
BMI
HSI
OR
CI
GLP-1
Full Text
1Introduction

Sleep duration is an important indicator of the state of human health. Several studies on the general population have reported that short sleep duration correlates with obesity, hypertension, diabetes mellitus, and cardiovascular diseases [1–3]. In one meta-analysis study, it was reported that insufficient sleep was associated with systemic chronic inflammatory disorders such as metabolic syndrome and an increase in the blood levels of inflammatory markers in patients with chronic diseases [4,5]. In addition, insufficient sleep adversely affects mental health [6]. Sleep duration is associated with various forms of human health.

The liver is essential for the maintenance of life and plays an important role in metabolism. Non-alcoholic fatty liver disease (NAFLD) is a metabolic liver disease caused by excessive accumulation of fat, and its prevalence is very high worldwide [7]. NAFLD is a term for a wide spectrum of pathological diseases ranging from simple steatosis to non-alcoholic steatohepatitis, which can progress to liver cirrhosis [8–10]. Furthermore, NAFLD is associated with an increased risk of metabolic conditions such as type 2 diabetes, cardiovascular diseases, obesity, metabolic syndrome, and insulin resistance [11,12]. Therefore, it is considered to be a serious disease according to recent clinical research.

Insufficient sleep was negatively correlated with liver fibrosis [13]. Insufficient sleep, as well as poor sleep quality, can trigger several pathophysiological processes that are associated with NAFLD [14]. The most common forms of sleep disturbance in NAFLD include obstructive sleep apnea (OSA), insomnia, and restless leg syndrome [15]. In particular, several studies investigating the prevalence of liver dysfunction in obstructive sleep apnea have reported that it is independently associated with elevated transaminases and progression to non-alcoholic steatohepatitis and liver fibrosis [16]. NAFLD patients have more than one feature of the metabolic syndrome, and now it is considered to be the hepatic component of this syndrome [17]. Therefore, the study of sleep duration can have important implications for public health and clinical studies related to chronic metabolic diseases.

Recently, people are not only required to do a lot of work in the community to which they belong but also have other personal activities, leading to insufficient sleep during the week. Therefore, some people can get enough sleep on both weekdays and weekends, while others cannot due to various enormous responsibilities during the week and compensate for this lack of sleep on weekends. This is called weekend catch-up sleep (WCUS), which is a sleep pattern to compensate for insufficient sleep during the week by sleeping for longer hours on weekends [18]. A previous study reported that there was a correlation between WCUS and obesity by directly and indirectly modulating the chronic inflammatory state of the human body [19]. Hwangbo et al. reported that WCUS was correlated with hypertension and metabolic syndrome [20].

Sleep duration is associated with NAFLD, but studies on the correlation between the various patterns of sleep and NAFLD are still lacking. In addition, WCUS is one of the most common sleep patterns among modern people, and it is related to obesity. However, its effect on fatty liver disease is unclear. We investigated the correlation between sleep duration, WCUS, and NAFLD using data from the Korea National Health and Nutrition Examination Survey (KNHANES).

2Methods2.1Participants

This study was based on the results of the KNHANES conducted from 2008 to 2019. The KNHANES is a highly representative national cross-sectional survey data that is managed by the Korea Disease Control and Prevention Agency. The KNHANES consists of strictly selected data by stratified multi-step probabilistic cluster sampling based on gender, age, and geographical area. The data included various past diseases, health surveys, nutritional status surveys of subjects, and clinical information such as blood tests, including aspartate aminotransferase (AST) and alanine aminotransferase (ALT).

A total of 101,138 subjects were registered in the KNHANES from 2008 to 2019, and the health survey reported the average daily sleep duration of all the participants over the past years. Since the KNHANES collected the sleep duration differently as of 2016, we divided the total data into Set 1 and Set 2 according to the type of sleep duration collected.

From 2008 to 2015, the mean sleep duration regardless of weekdays and weekends were collected (Set 1; n = 68,759), while KHANES data were collected separately for mean weekday and weekend sleep duration from 2016 to 2019 (Set 2; n = 32,379). Among them, we excluded subjects who were less than 20 years (n = 16,679 in Set 1 and n = 6640 in Set 2), with hepatitis B and C infections (n = 1834 in Set 1 and n = 931 in Set 2), liver cirrhosis or liver cancer (n = 85 in Set 1 and n = 48 in Set 2), shift workers and others who slept irregularly (n = 13,652 in Set 1 and n = 8840 in Set 2), and those who consume alcohol excessively (more than 210 g/week for male, more than 140 g/week for women; n = 2175 in Set 1 and n = 1322 in Set 2). Subjects with missing data on major blood tests, clinical information, and sleep duration were excluded from the analysis (n = 7346 in Set 1 and n = 2884 in Set 2) (Fig. 1).

Fig. 1.

Study design.

(0.44MB).

The study was approved by the Medical Institution Ethics Committee of the International St. Mary's Hospital (IRB No. IS21EISI0076).

2.2Measurements of clinical and biochemical variables

The smoking status was classified as follows: non-smoker, former smoker, or current smoker. Alcohol consumption was calculated as the amount of alcohol intake in grams based on the number of drinks per week or month and the average number of drinks consumed at a time. Body mass index (BMI) was calculated by dividing the weight (kg) by the square of the height (kg/m2). Obesity was defined as BMI ≥ 25 kg/m2. The average of two–three blood pressure measurements was recorded. Hypertension was considered when the systolic blood pressure was > 140 mmHg and/or the diastolic blood pressure was > 90 mmHg, or the subject was on antihypertensive medication. Venous blood samples were collected for blood testing after fasting for 8 hours and the levels of fasting blood sugar, AST, ALT, triglycerides, and cholesterol were measured. Individuals whose fasting blood sugar level was > 126 mg/dL or who had previously been diagnosed with diabetes by a doctor were classified as having diabetes. Hypertriglyceridemia was considered when the triglyceride level was greater than or equal to 200 mg/dL. Metabolic syndrome was defined based on the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) [21].

2.3Definition of sleep habits, WCUS, significant steatosis

In Set 1, the group was divided into a group that slept more than 7 hours and a group that slept less than 7 hours according to the average duration of sleep per week. In Set 2, the group was also divided based on 7 hours of sleep duration and the data was analyzed for weekdays and weekends, respectively. In addition, in Set 2, sleep patterns in which sleep less than 7 hours during the week but supplemented for more than 7 hours on weekends were defined as WCUS. Therefore, subjects who had less than 7 hours of sleep during the weekdays and did not have WCUS were classified into Group 1, subjects who had less than 7 hours of sleep during the weekdays and had WCUS were classified into Group 2, and subjects who had more than 7 hours of sufficient sleep also during the weekdays were classified into Group 3.

For fatty liver, the hepatic steatosis index (HSI) was used to determine the presence of a fatty liver. The HSI was calculated as follows: his = 8 × (ratio of ALT/AST) + BMI (+ 2 for female, + 2 in case of diabetes). HSI is an indicator developed based on the medical examination of the subjects whose fatty liver condition was assessed by ultrasound, and an HSI of greater than or equal to 36 was considered as an indicator of fatty liver [22].

We separated the data from sets 1 and 2 according to the forms from the survey of sleep duration and studied the correlation between sleep duration and NAFLD within each set.

2.4Statistical analyses

All statistical analyses were performed using the R software version 4.1.1. The baseline characteristics were expressed as mean ± standard deviation for continuous variables or as percentages for categorical variables. The significance of differences in continuous variables between the two groups was investigated using the independent t-tests. The significance of differences in categorical variables was determined using the chi-square test. Multiple logistic regression analysis was performed to determine the effect of sleep duration and WCUS on HSI ≥ 36 after adjusting for covariates. A p-value of < 0.05 was considered statistically significant.

3Results3.1Baseline participants characteristics

Set 1 included 26,988 subjects and Set 2 included a total of 11,714 subjects. In Set 1, there were 12,372 male subjects (45.8%), 20,345 city dwellers (75.3%), and 23,100 married persons (85.5%). There were 8675 (32.1%), 2481 (9.1%), 7726 (28.6%), and 3437 (12.7%) people with obesity, diabetes, hypertension, and hyperlipidemia, respectively. The mean AST, ALT, serum glucose, and total cholesterol levels were 21.8 IU/L (± 10.7), 21.4 IU/L (± 16.2), 98.2 mg/dL (± 22.8), and 189.3 mg/dL (± 35.5), respectively. Collected without distinction between weekday and weekend time in Set 1, the mean sleep duration of the subjects in Set 1 was 6.8 hours (± 1.3 hours), and 15,825 (58.6%) subjects had more than 7 hours of sleep during the entire week.

In Set 2, there were 5873 male subjects (50.1%), 9452 city dwellers (80.7%), and 9595 married persons (81.9%). There were 4125 people with obesity (35.2%), 1228 people with diabetes (10.5%), 3153 people with hypertension (26.9%), and 2494 people with hyperlipidemia (21.3%). With respect to the blood tests, the mean AST, ALT, serum glucose, and total cholesterol levels were 23.0 IU/L (± 11.1), 23.0 IU/L (± 17.4), 100.7 mg/dL (± 23.3), and 194.8 mg/dL (± 37.0), respectively. The average sleep duration during the weekdays of Set 2 subjects was 6.9 hours (± 1.2 h), and 7026 subjects had an average sleep time of more than 7 hours (59.9%). The mean duration of sleep during the weekend was 7.7 hours (± 1.5 hours). The basic features of all the subjects are described in Table 1.

Table 1.

Clinical characteristics in the study population in Set 1.

Characteristics  Set 1 (n = 26,988)Set 2 (n = 11,714)
  Total    HSI  P  Total    HSI  P 
    <36  ≥ 36      <36  ≥ 36   
  26,988  20,989  5999    11,714  8926  2788   
Sleep duration (h/days)                 
on all weeks  6.8 ± 1.3  6.8 ± 1.3  6.7 ± 1.3  <0.001         
on weekdays          6.9 ± 1.2  7.0 ± 1.2  6.8 ± 1.3  <0.001 
on weekends          7.7 ± 1.5  7.7 ± 1.5  7.5 ± 1.5  <0.001 
Age, years  48.9 ± 15.3  48.7 ± 15.7  48.5 ± 14.0  0.326  48.3 ± 14.7  48.6 ± 15.1  47.5 ± 13.6  <0.001 
Gender        <0.001        <0.001 
Men  12,372  9261 (44.1%)  3,111 (51.9%)    5873  4169 (46.7%)  1704 (61.1%)   
Women  14,616  11,728(55.9%)  2888 (48.1%)    5841  4757 (53.3%)  1084 (38.9%)   
Residential district        0.557        0.003 
Urban area  20,345  15,821(75.4%)  4524 (75.4%)    9452  7257 (81.3%)  2195 (78.7%)   
Rural area  6643  5168 (24.6%)  1475 (24.6%)    2262  1669 (18.7%)  593 (21.3%)   
Marital status        <0.001        0.372 
Married  23,100  17,825(84.9%)  5275 (87.9%)    9595  7295 (81.7%)  2300 (82.5%)   
Unmarried  3852  3135 (14.9%)  717 (12.0%)    2119  1631 (18.3%)  488 (17.5%)   
Divorced, etc  35  29 (0.1%)  6 (0.1%)           
Household income        0.006        0.002 
Low  4573  3591 (17.3%)  982 (16.6%)    1410  1108 (12.4%)  302 (10.8%)   
Low Middle  6565  5032 (24.3%)  1533 (25.9%)    2,705  2042 (22.9%)  663 (23.8%)   
Middle High  7586  5862 (28.3%)  1724 (29.1%)    3481  2589 (29.0%)  892 (32.0%)   
High  7948  6265 (30.2%)  1683 (28.4%)    4,103  3176 (35.6%)  927 (33.3%)   
Occupation        <0.001        0.032 
Agriculture  5884  4711 (22.5%)  1173 (19.7%)    2164  1673 (18.8%)  491 (17.6%)   
Blue collar  3051  2295 (11.0%)  756 (12.7%)    1712  1259 (14.2%)  453 (16.3%)   
White collar  7399  5760 (27.5%)  1,639 (27.5%)    4628  3561 (40.0%)  1067 (38.4%)   
Pink collar  3815  2865 (13.7%)  950 (15.9%)    1889  1421 (16.0%)  468 (16.8%)   
Unemployment  6730  5290 (25.3%)  1440 (24.2%)    1286  983 (11.0%)  303 (10.9%)   
Education level        0.039        0.883 
Elementary school  6468  4960 (23.7%)  1,508 (25.2%)    1694  1291 (14.5%)  403 (14.5%)   
Middle school  2944  2276 (10.9%)  668 (11.2%)    1035  787 (8.8%)  248 (8.9%)   
High school  8628  6881 (32.8%)  1,947 (32.5%)    3637  2756 (30.9%)  881 (31.6%)   
College  8722  6855 (32.7%)  1867 (31.2%)    5347  4091 (45.8%)  1256 (45.1%)   
Smoking        <0.001        <0.001 
Never  15,637  12,428(59.2%)  3209 (53.5%)    6719  5322 (59.6%)  1397 (50.1%)   
Past  3384  2638 (12.6%)  746 (12.4%)    2702  2006 (22.5%)  696 (25.0%)   
Current  7962  5919 (28.2%)  2043 (34.1%)    2289  1595 (17.9%)  694 (24.9%)   
Chronic disease                 
Hypertension  7726  5211 (24.9%)  2515 (42.1%)  <0.001  3153  2048 (23.0%)  1105 (39.8%)  <0.001 
Diabetes  2481  1168 (5.7%)  1313 (22.4%)  <0.001  1228  665 (7.6%)  563 (20.7%)  <0.001 
Hypercholesterolemia  3437  2205 (10.7%)  1232 (21.1%)  <0.001  2494  1649 (18.8%)  845 (31.0%)  <0.001 
Hypertriglyceridemia  3217  1891 (11.7%)  1326 (29.2%)  <0.001  1360  742 (10.5%)  618 (28.5%)  <0.001 
Cardiovascular disease  466  342 (1.7%)  124 (2.1%)  <0.001  180  135 (1.5%)  45 (1.6%)  0.641 
Stroke  507  370 (1.8%)  137 (2.4%)  <0.001  245  199 (2.3%)  46 (1.7%)  0.09 
BMI (kg/m223.7 ± 3.3  22.6 ± 2.5  27.7 ± 2.9  <0.001  24.0 ± 3.5  22.7 ± 2.5  28.2 ± 3.1  <0.001 
BMI>25  8675  3609 (17.2%)  5,066 (84.4%)  <0.001  4125  1691 (18.9%)  2434 (87.3%)  <0.001 
AST (IU/L)  21.8 ± 10.7  20.8 ± 10.1  25.4 ± 12.0  <0.001  23.0 ± 11.1  21.7 ± 10.2  27.0 ± 12.7  <0.001 
ALT (IU/L)  21.4 ± 16.2  17.3 ± 9.6  35.5 ± 24.6  <0.001  23.0 ± 17.4  18.1 ± 9.7  38.8 ± 25.4  <0.001 
Glucose (mg/dl)  98.2 ± 22.8  95.3 ± 18.2  108.7 ± 32.2  <0.001  100.7 ± 23.3  97.6 ± 18.9  110.4 ± 31.8  <0.001 
Total cholesterol (mg/dl)  189.3 ± 35.5  186.8 ± 34.7  198.2 ± 36.9  <0.001  194.8 ± 37.2  193.3 ± 36.1  199.4 ± 40.3  <0.001 
LDL-C (mg/dl)  114.2 ± 32.0  111.8 ± 31.3  120.7 ± 33.2  <0.001  120.1 ± 35.6  117.3 ± 34.8  124.0 ± 36.3  <0.001 
HDL-C (mg/dl)  49.0 ± 11.5  50.3 ± 11.6  44.5 ± 9.9  <0.001  51.4 ± 12.6  53.1 ± 12.7  46.0 ± 10.4  <0.001 
Triglycerides (mg/dl)  134.6 ± 106.3  121.8 ± 95.9  179.6 ±126.7  <0.001  136.0 ± 111.1  122.0± 102.3  180.7± 125.6  <0.001 

*ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.

Continuous variables are expressed as means and standard deviations. Categorical variables are expressed as numbers and percentages

3.2Relationship between sleep habits and HSI

In all Set 1 subjects, the mean sleep duration of 7 hours or more was associated with a negative OR for NAFLD compared with less than 7 hours of sleep duration (odds ratio [OR]: 0.84, 95% confidence interval [CI]; 0.79–0.89 for all; OR; 0.91, 95%CI; 0.84–0.99 for male subjects; OR: 0.86, 95%CI; 0.79–0.94 for female subjects) (Table 2).

Table 2.

Associations between sleep duration and quality and the risk of fatty liver in clinically relevant subgroups.

SubgroupTotalMenWomen
  Sleep duration (h)  N  Multivariate OR (95% CI)  N  OR (95% CI)  N  OR (95% CI) 
Set 1  <7  11,163  1.00 (Reference)  5175  1.00 (Reference)  5988  1.00 (Reference) 
  ≥7  15,825  0.84 (0.79 - 0.89)  7197  0.91 (0.84 - 0.99)  8628  0.86 (0.79 - 0.94) 
Set 2  <7  4688  1.00 (Reference)  2415  1.00 (Reference)  2273  1.00 (Reference) 
Weekdays  ≥7  7026  0.81 (0.74 - 0.89)  3458  0.88 (0.78 - 0.99)  3568  0.79 (0.68 - 0.90) 
Set 2  <7  2644  1.00 (Reference)  1,359  1.00 (Reference)  1285  1.00 (Reference) 
Weekends  ≥7  9070  0.78 (0.70 - 0.87)  4514  0.82 (0.71 - 0.94)  4556  0.76 (0.65 - 0.89) 

*The risk of sleep duration on the prevalence of hepatic steatosis in (A) total, (B) men, and (C) women.

Adjusted for age (continuous), residence, education, marital status, smoking (never, former, current), alcohol consumption (g/week), systolic blood pressure, and serum total cholesterol.

In Set 2 subjects, the mean sleep duration of 7 hours or more during the weekdays was associated with a negative OR for NAFLD compared with less than 7 hours sleep duration (OR: 0.81, 95%CI: 0.74–0.89 for all; OR: 0.88, 95%CI: 0.78–0.99 for male subjects; OR: 0.79, 95%CI: 0.68–0.90 for female subjects) (Table 2). Set 2 subjects with a mean sleep duration of 7 hours or more during the weekend was associated with a negative OR for NAFLD (OR: 0.78, 95%CI: 0.70–0.87 for all; OR: 0.82, 95%CI: 0.71–0.94 for male subjects; OR: 0.76, 95%CI: 0.65–0.89 for female subjects) (Table 2).

3.3Relationship between sleep habits and HSI according to WCUS

In Set 2, which consists of data separated according to the duration of sleep on weekdays and weekends, there were 2365 (20.2%) subjects who slept for less than 7 hours during the week and could not catch up on weekends (Group 1); 2602 (22.2%) subjects who slept for less than 7 hours during the week and had WCUS (Group 2); and 6747 (57.6%) subjects who slept for more than 7 hours during the week (Group 3).

Based on Group 1, the OR of Group 2 was 0.80 for NAFLD (95%CI: 0.70–0.92), and the OR of Group 3 was 0.73 (95%CI: 0.66–0.82) (Fig. 2). In men, based on Group 1, the ORs for Groups 2 and 3 for NAFLD were 0.80 (95%CI: 0.66–0.94) and 0.79 (95%CI: 0.68–0.92), respectively, which showed a significant correlation. In women, based on Group 1, the ORs of Group 2 and Group 3 for NAFLD were 0.81 (95%CI: 0.65–0.99) and 0.72 (95%CI: 0.60–0.85), respectively (Fig. 2). In the sub-analysis of subjects with obesity, the ORs of Group 2 and Group 3 based on Group 1 were 0.81 (95%CI: 0.67–0.99) and 0.84 (95%CI: 0.72–0.99), respectively. In the subjects with metabolic syndrome, the ORs of Group 2 and Group 3, based on Group 1 were 0.72 (95%CI: 0.57–0.91) and 0.77 (95%CI: 0.64–0.92), respectively (Fig. 3).

Fig. 2.

The odds ratio (OR) for non-alcoholic fatty liver disease according to the sleep pattern (Group 1: less than 7 hours of sleep during the entire week, Group 2: Weekend catch up sleep, Group 3: 7 or more than 7 hours of sleep during the entire week); (A) entire cohort, (B) male subjects, (C) female subjects.

(0.11MB).
Fig. 3.

The odds ratio (OR) for non-alcoholic fatty liver disease according to the sleep pattern (Group 1: less than 7 hours of sleep during the entire week, Group 2: Weekend catch up sleep, Group 3: 7 or more than 7 hours of sleep during the entire week); (A) obesity, (B) metabolic syndrome.

(0.08MB).
3.4Relationship between WCUS and abnormal ALT and obesity

For ALT ≥ 40 IU/L, based on Group 1, the OR of Group 2 was 0.76 (95%CI: 0.63–0.92) and the OR of Group 3 was 0.75 (95%CI: 0.64–0.88). For BMI ≥ 25 kg/m2, based on Group 1, the OR of Group 2 was 0.87 (95%CI: 0.77–0.98) and the OR of Group 3 was 0.77 (95%CI: 0.70–0.86).

4Discussion

From the analysis of the data from the KNHANES (2008–2015) in this study, less than 7 hours of sleep showed a significant correlation with HSI ≥ 36, suggestive of NAFLD. Even when the sleep duration is analyzed by dividing it into weekdays and weekends using the KNHANES data (2016–2019), less than 7 hours of sleep showed a significant correlation with HSI ≥ 36. In addition, when separated into male and female subjects, less than 7 hours of sleep in both male and female subjects showed a significant correlation with HSI ≥ 36.

There are some plausible mechanisms that link the decrease in sleep and NAFLD. Hypothalamic–pituitary–adrenal axis and autonomic nervous system activities are important in the regulation of physical and mental health conditions. Cortisol, inflammatory cytokines, and norepinephrine, which are derivatives of these systems, are associated with the variation in sleep such as total sleep time, sleep quality, sleep efficiency, and circadian midpoint. The dysregulation of this axis caused by changes in sleep can increase the risk of NAFLD onset [23].

Leptin may be also considered a physiologic cause of metabolic disease. This peptide hormone secreted by the adipose tissue from a molecular physiological perspective promotes satiety. The blood concentration of leptin is closely related to the sleep duration [24]. A decrease in sleep duration results in a decrease in leptin concentration and an increase in the activity of the food reward system. This leads to an increase in calorie intake and weight gain. In addition, a decrease in sleep duration causes a decrease in the intestinal-derived peptide, glucagon-like peptide-1 (GLP-1), and GLP-1 delays gastric emptying and promotes satiety [25]. The physiological background on the development of obesity can explain the occurrence of NAFLD due to reduced sleep duration.

Sleep duration is an important factor that affects the development of diabetes and cardiovascular diseases. A previous meta-analysis reported a significant correlation between sleep duration and the development of diabetes [26]. A previous epidemiological study reported that insufficient sleep duration increases the risk of developing cardiovascular diseases [27,28]. In addition, Hoevenaar-Blom et al. reported that sufficient sleep can reduce the risk of cardiovascular diseases [29]. According to a study by Kwon et al., sleep duration is a factor that can predict not only the mortality rate of cardiovascular diseases but also cancer. Therefore, it can be inferred that sleep duration is closely related not only to the occurrence of a disease but also to its survival rate [30].

NAFLD is a metabolic disease. It is a major risk factor for obesity, diabetes, and cardiovascular diseases. It can progress to cirrhosis or liver cancer. Fatty liver has several causes, and insufficient sleep is closely related to NAFLD. Kim et al. reported that poor sleep quality and reduced sleep duration are significantly correlated with the occurrence of NAFLD [14]. An inadequate sleep habit affects the hormone metabolism of the body, which can lead to obesity, metabolic syndrome, and NAFLD.

In a previous report, WCUS was reported to be significantly correlated with a decrease in the incidence of metabolic syndrome [31]. In that study, it was found that WCUS can reduce the OR of metabolic syndrome by 45%. This present study revealed a significant correlation between sleep duration and HSI. Our result is similar to that of a previous study which showed a correlation between overall sleep duration and chronic metabolic disease. Furthermore, NAFLD is associated with WCUS. In modern societies, it is difficult for people to get enough sleep during the week leading to sleep supplementation on weekends. In our study, Group 2 of the WCUS accounted for approximately 22.2%. When Group 1 was used as a reference, the ORs of Group 2 and Group 3 for NAFLD were 0.80 (CI: 0.70–0.92) and 0.73 (CI: 0.66–0.82), respectively. Our study revealed that people who get enough sleep have a lower risk of developing NAFLD than those who get insufficient sleep. Furthermore, we revealed that people who had WUCS have a lower risk of developing NAFLD than those who did not get enough sleep, even on weekends.

When analyzed in men and women, the largest negative correlation of 7 hours or more of sleep was higher than less than 7 hours with NAFLD, and a negative correlation was observed in the WCUS group with NAFLD. WCUS was found to be highly correlated with the incidence of NAFLD, regardless of sex.

Other results support the correlation between WCUS and NAFLD. Reduced total sleep duration showed a significant relationship with ALT of 40 IU/L or higher. In addition, those who had enough sleep during both weekdays and weekends or WCUS showed a negative relationship with an ALT of 40 IU/L or higher. Similar results were also obtained with obesity, which is a known prognostic factor of chronic diseases. Those who had 7 hours or more of sleep on weekdays and weekends and those who had WCUS showed a negative correlation with obesity in our study. Based on these results, it is thought that WCUS is significantly correlated with NAFLD. No research has shown how WCUS relieves the fatty liver in animal experiments and other clinical studies, however, we have suggested that sleep supplementation during weekends may ease oxidative stress and inflammation in the liver.

This study had some limitations. First, this was a cross-sectional study. Therefore, it is not known whether insufficient sleep duration is a causal factor of NAFLD. However, the KNHANES is a representative national survey data, and the sample size is large. It is a major discovery that there is a high correlation between WCUS and NAFLD. Second, sleep duration was not an individually observed measure. However, since the data was from a national survey it was considered highly reliable because it was collected by survey experts. Third, the gold standard method of diagnosing NAFLD is a biopsy, and our study did not include histological results. However, due to the high cost of biopsy and the complications related to biopsy, non-invasive diagnostic methods have been widely used in recent research [32]. HSI is a representative method for diagnosing NAFLD [22].

In conclusion, the overall sleep duration and WCUS were negatively correlated with NAFLD (HSI ≥ 36). In the future, the causal relationship between WCUS and NAFLD should be prospectively studied to enhance the proper concepts and methods of sleep hygiene. Based on this study, it is expected that the methods of treatment of NAFLD will be expanded since there is no clear treatment of NAFLD other than improving eating habits or weight loss.

Funding

This study was supported by National Research Foundation of Korea (grant number 2018R1C1B5043143). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Contributions

Sangheun Lee: Visualization, Conceptualization, Writing – review & editing, Methodology, Supervision, Funding acquisition, Yongsang Seo: Writing – original draft, Data curation, Gi-Ho Sung: Data curation, Formal analysis, Ki Jun Han: Writing – review & editing

Data sharing statement

Data are available in a public, open access repository.

Acknowledgement

We gratefully acknowledge the Korea National Health and Nutrition Examination Surveys (KNHANES) from the Korea Centers for Disease Control and Prevention.

References
[1]
MH Hall, MF Muldoon, JR Jennings, et al.
Self-reported sleep duration is associated with the metabolic syndrome in midlife adults.
Sleep, 31 (2008), pp. 635-643
[2]
E Kronholm, T Laatikainen, M Peltonen, et al.
Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland.
Sleep Med, 12 (2011), pp. 215-221
[3]
S Taheri, L Lin, D Austin, et al.
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index.
[4]
IH Iftikhar, MA Donley, J Mindel, et al.
Sleep duration and metabolic syndrome. An updated dose-risk metaanalysis.
Ann Am Thorac Soc, 12 (2015), pp. 1364-1372
[5]
N Simpson, DF. Dinges.
Sleep and inflammation.
[6]
S Wang, B Li, Y Wu, et al.
Relationship of sleep duration with sociodemographic characteristics, lifestyle, mental health, and chronic diseases in a large Chinese adult population.
J Clin Sleep Med, 13 (2017), pp. 377-384
[7]
M Lazo, JM. Clark.
The epidemiology of nonalcoholic fatty liver disease: a global perspective.
Semin Liver Dis, 28 (2008), pp. 339-350
[8]
LA Adams, S Sanderson, KD Lindor, et al.
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
J Hepatol, 42 (2005), pp. 132-138
[9]
SH Caldwell, DM. Crespo.
The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease.
J Hepatol, 40 (2004), pp. 578-584
[10]
G Baffy, EM Brunt, SH. Caldwell.
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
J Hepatol, 56 (2012), pp. 1384-1391
[11]
G Targher, CP Day, E. Bonora.
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
N Engl J Med, 363 (2010), pp. 1341-1350
[12]
LA Adams, OR Waters, MW Knuiman, et al.
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
Am J Gastroenterol, 104 (2009), pp. 861-867
[13]
J Zheng, S Chen, Y Cai, et al.
Insufficient nocturnal sleep was associated with a higher risk of fibrosis in patients with diabetes with metabolic associated fatty liver disease.
Ther Adv Endocrinol Metab, 11 (2020),
[14]
CW Kim, KE Yun, HS Jung, et al.
Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses.
J Hepatol, 59 (2013), pp. 351-357
[15]
HM Mir, M Stepanova, H Afendy, et al.
Association of sleep disorders with nonalcoholic fatty liver disease (NAFLD): a population-based study.
J Clin Exp Hepatol, 3 (2013), pp. 181-185
[16]
J Aron-Wisnewsky, C Minville, J Tordjman, et al.
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
J Hepatol, 56 (2012), pp. 225-233
[17]
L Abenavoli, N Milic, L Di Renzo, et al.
Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
World J Gastroenterol, 22 (2016), pp. 7006-7016
[18]
WY Huang, SHS. Wong.
Prospective associations between weekend catch-up sleep, physical activity, and childhood obesity.
Child Obes, 15 (2019), pp. 40-47
[19]
HJ Im, SH Baek, MK Chu, et al.
Association between weekend catch-up sleep and lower body mass: population-based study.
[20]
Y Hwangbo, WJ Kim, MK Chu, et al.
Association between weekend catch-up sleep duration and hypertension in Korean adults.
Sleep Med, 14 (2013), pp. 549-554
[21]
Expert Panel on Detection.
Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
JAMA, 285 (2001), pp. 2486-2497
[22]
JH Lee, D Kim, HJ Kim, et al.
Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.
Dig Liver Dis, 42 (2010), pp. 503-508
[23]
DC Slavish, DJ Taylor, KL. Lichstein.
Intraindividual variability in sleep and comorbid medical and mental health conditions.
Sleep, 42 (2019), pp. zsz052
[24]
RM Cassidy, Q. Tong.
Hunger and satiety gauge reward sensitivity.
Front Endocrinol (Lausanne), 8 (2017), pp. 104
[25]
LL Baggio, DJ. Drucker.
Biology of incretins: GLP-1 and GIP.
Gastroenterology, 132 (2007), pp. 2131-2157
[26]
Z Shan, H Ma, M Xie, et al.
Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies.
Diabetes Care, 38 (2015), pp. 529-537
[27]
C Wang, SI Bangdiwala, S Rangarajan, et al.
Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries.
Eur Heart J, 40 (2019), pp. 1620-1629
[28]
S Ikehara, H Iso, C Date, et al.
Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study.
Sleep, 32 (2009), pp. 295-301
[29]
MP Hoevenaar-Blom, AM Spijkerman, D Kromhout, et al.
Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study.
Eur J Prev Cardiol, 21 (2014), pp. 1367-1375
[30]
S Kwon, H Lee, JT Lee, et al.
Sleep duration and mortality in Korean adults: a population-based prospective cohort study.
BMC Public Health, 20 (2020), pp. 1623
[31]
SM Son, EJ Park, YH Cho, et al.
Association between weekend catch-up sleep and metabolic syndrome with sleep restriction in Korean adults: a cross-sectional study using KNHANES.
Diabetes Metab Syndr Obes, 13 (2020), pp. 1465-1471
[32]
M Balakrishnan, A Seth, N Cortes-Santiago, et al.
External validation of four point-of-care noninvasive scores for predicting advanced hepatic fibrosis in a predominantly Hispanic NAFLD population.
Dig Dis Sci, 66 (2021), pp. 2387-2393

Yongsang Seo and Gi-Ho Sung share primary co-authorship.

Copyright © 2022. Fundación Clínica Médica Sur, A.C.
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos